CRISPR Therapeutics is changing up its cell therapy plans, announcing Monday it will shelve its most advanced cancer drug prospects and pursue cell-based medicines for autoimmune diseases.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,